Partnering refers to the process of enabling one or more services to provide secure communication and collaboration between Merck and its external business partners.
EngageZone aims to enhance collaboration among our partners - Clinical Investigators, Contract Manufacturing Organizations and Clinical Researchers. Our goal is to provide Investigators, Sponsors, Researchers and Contract Research Organization partners with a robust way to access and exchange information. The introduction of EngageZone is an example how Merck will continue to lead the pharmaceutical industry by becoming Your Partner of Choice.
At Merck, our clinical trials are designed, conducted and monitored in adherence to the same standards, whether they take place in the United States or elsewhere around the world. In conducting clinical trials, we also adhere to the guidelines of The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use.
Merck-sponsored clinical trials in patients are registered on ClinicalTrials.gov, a service of the U.S. National Institutes of Health. Links to Merck sponsored clinical trials by phase are found in Explore our Pipeline. Information about ongoing clinical trials is also available online through the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA).
Interested in Conducting Merck Clinical Trials?
Submit your profile to become a potential Clinical Trial Investigator for a Merck Clinical Trial. (US physicians only at this time)
Investigator Initiated Studies
The IIS Program consists of committees of medical and scientific staff from different therapeutic areas who meet to review investigator study proposals. Use this link if you are interested in learning more about the IIS Program.